B Cell Growth Modulating and Differentiating Activity of Recombinant Human 26-kd Protein (BSF-2, HuIFN-beta 2, HPGF)

Overview

Journal EMBO J

Specialties Biotechnology
Molecular Biology

Date 1987 May 1

PMID 3497029

Citations 48

Authors

P Poupart

P Vandenabeele

S Cayphas

J Van Snick

G Haegeman

V Kruys

W Fiers

J Content

Affiliations

Soon will be listed here.

Abstract

The human "26-kd protein' is a secreted glycoprotein expressed, for example, in (blood) leukocytes, in epithelial cells treated with various inducers, but most strongly in interleukin-1 (IL-1)-treated fibroblasts. After finding it has antiviral and 2-5A synthetase-inducing activity, one group of authors called this protein IFN-beta 2. However, recently the full-length 26-kd cDNA sequence was shown to be identical with that of a B-cell-differentiating lymphokine called BSF-2, and another report suggested that the 26-kd protein could support the growth of some transformed murine B cell lines. To define its biological activities, we expressed the recombinant 26-kd protein by translating in Xenopus laevis oocytes a pure, synthetic chimeric mRNA containing the 26-kd protein coding region surrounded by Xenopus laevis beta-globin untranslated regions. A similar construction, but containing the HuIFN-beta cDNA coding region, was used to produce HuIFN-beta by the same procedure. Both recombinant glycoproteins were secreted, glycosylated, and their amounts were measured by [35S]methionine incorporation by the oocyte. Here we show that the recombinant 26-kd protein exhibits a high growth factor activity when assayed on an IL-HP1-dependent murine B cell hybridoma (sp. act. approximately 2 X 10(8) U/mg) as well as a potent differentiating activity on human CESS cells (sp. act. approximately 5 X 10(7) U/mg). While rHuIFN-beta was inactive in the latter two assays, it had the expected antiviral activity of 1-5 X 10(8) U/mg. The parallel recombinant 26-kd protein preparations had no detectable antiviral activity (i.e. a maximal specific activity of 1-3 X 10(2) U/mg, if any). The 26-kd protein is thus clearly an interleukin, and considering the confusing nomenclature now in use, this factor may better be renamed "interleukin 6'.

Citing Articles

Defective N-glycosylation of IL6 induces metastasis and tyrosine kinase inhibitor resistance in lung cancer.

Hung C, Wu S, Yao C, Yeh H, Lin C, Chu C Nat Commun. 2024; 15(1):7885.

PMID: 39251588 PMC: 11385228. DOI: 10.1038/s41467-024-51831-7.

Role of Interleukin 6 in Acute Pancreatitis: A Possible Marker for Disease Prognosis.

Mititelu A, Grama A, Colceriu M, Benta G, Popoviciu M, Pop T Int J Mol Sci. 2024; 25(15).

PMID: 39125854 PMC: 11311934. DOI: 10.3390/ijms25158283.

Tocilizumab in pediatric rheumatology: the clinical experience.

Gurion R, Singer N Curr Rheumatol Rep. 2013; 15(7):338.

PMID: 23715975 DOI: 10.1007/s11926-013-0338-y.

Hematopoietic growth factor receptors.

Shieh J, Moore M Cytotechnology. 2012; 2(4):269-86.

PMID: 22358869 DOI: 10.1007/BF00364993.

Interactions between rnacrophage cytokines and eicosanoids in expression of antitumour activity.

Ben-Efraim S Mediators Inflamm. 1992; 1(5):295-308.

PMID: 18475475 PMC: 2365362. DOI: 10.1155/S0962935192000449.

References

Gurdon J . Changes in somatic cell nuclei inserted into growing and maturing amphibian oocytes. J Embryol Exp Morphol. 1968; 20(3):401-14. View

Van Snick J, Vink A, Cayphas S, Uyttenhove C . Interleukin-HP1, a T cell-derived hybridoma growth factor that supports the in vitro growth of murine plasmacytomas. J Exp Med. 1987; 165(3):641-9. PMC: 2188283. DOI: 10.1084/jem.165.3.641. View

Weissenbach J, Zeevi M, Landau T, Revel M . Identification of the translation products of human fibroblast interferon mRNA in reticulocyte lysates. Eur J Biochem. 1979; 98(1):1-8. DOI: 10.1111/j.1432-1033.1979.tb13153.x. View

KNIGHT Jr E, Hunkapiller M, Korant B, Hardy R, HOOD L . Human fibroblast interferon: amino acid analysis and amino terminal amino acid sequence. Science. 1980; 207(4430):525-6. DOI: 10.1126/science.7352259. View

Derynck R, Remaut E, Saman E, Stanssens P, De Clercq E, Content J . Expression of human fibroblast interferon gene in Escherichia coli. Nature. 1980; 287(5779):193-7. DOI: 10.1038/287193a0. View

Weissenbach J, Chernajovsky Y, Zeevi M, Shulman L, Soreq H, Nir U . Two interferon mRNAs in human fibroblasts: in vitro translation and Escherichia coli cloning studies. Proc Natl Acad Sci U S A. 1980; 77(12):7152-6. PMC: 350459. DOI: 10.1073/pnas.77.12.7152. View

Content J, De Wit L, Pierard D, Derynck R, De Clercq E, Fiers W . Secretory proteins induced in human fibroblasts under conditions used for the production of interferon beta. Proc Natl Acad Sci U S A. 1982; 79(9):2768-72. PMC: 346287. DOI: 10.1073/pnas.79.9.2768. View

White B, Bancroft F . Cytoplasmic dot hybridization. Simple analysis of relative mRNA levels in multiple small cell or tissue samples. J Biol Chem. 1982; 257(15):8569-72. View

Contreras R, Cheroutre H, Degrave W, Fiers W . Simple, efficient in vitro synthesis of capped RNA useful for direct expression of cloned eukaryotic genes. Nucleic Acids Res. 1982; 10(20):6353-62. PMC: 326924. DOI: 10.1093/nar/10.20.6353. View

10.

Chebath J, Merlin G, Metz R, Benech P, Revel M . Interferon-induced 56,000 Mr protein and its mRNA in human cells: molecular cloning and partial sequence of the cDNA. Nucleic Acids Res. 1983; 11(5):1213-26. PMC: 325791. DOI: 10.1093/nar/11.5.1213. View

11.

Landegren U . Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Applications to detection of lymphokines and cell surface antigens. J Immunol Methods. 1984; 67(2):379-88. DOI: 10.1016/0022-1759(84)90477-0. View

12.

Rinderknecht E, OConnor B, Rodriguez H . Natural human interferon-gamma. Complete amino acid sequence and determination of sites of glycosylation. J Biol Chem. 1984; 259(11):6790-7. View

13.

Poupart P, De Wit L, Content J . Induction and regulation of the 26-kDa protein in the absence of synthesis of beta-interferon mRNA in human cells. Eur J Biochem. 1984; 143(1):15-21. DOI: 10.1111/j.1432-1033.1984.tb08332.x. View

14.

Krieg P, Melton D . Functional messenger RNAs are produced by SP6 in vitro transcription of cloned cDNAs. Nucleic Acids Res. 1984; 12(18):7057-70. PMC: 320142. DOI: 10.1093/nar/12.18.7057. View

15.

Roberts A, Anzano M, Wakefield L, Roche N, Stern D, Sporn M . Type beta transforming growth factor: a bifunctional regulator of cellular growth. Proc Natl Acad Sci U S A. 1985; 82(1):119-23. PMC: 396983. DOI: 10.1073/pnas.82.1.119. View

16.

Hirano T, Taga T, Nakano N, Yasukawa K, Kashiwamura S, Shimizu K . Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). Proc Natl Acad Sci U S A. 1985; 82(16):5490-4. PMC: 391148. DOI: 10.1073/pnas.82.16.5490. View

17.

Content J, De Wit L, Poupart P, Opdenakker G, Van Damme J, Billiau A . Induction of a 26-kDa-protein mRNA in human cells treated with an interleukin-1-related, leukocyte-derived factor. Eur J Biochem. 1985; 152(2):253-7. DOI: 10.1111/j.1432-1033.1985.tb09191.x. View

18.

Wathelet M, Moutschen S, Defilippi P, Cravador A, Collet M, Huez G . Molecular cloning, full-length sequence and preliminary characterization of a 56-kDa protein induced by human interferons. Eur J Biochem. 1986; 155(1):11-7. DOI: 10.1111/j.1432-1033.1986.tb09452.x. View

19.

Kohase M, May L, Vilcek J, Sehgal P . Induction of beta 2-interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferation. Cell. 1986; 45(5):659-66. DOI: 10.1016/0092-8674(86)90780-4. View

20.

Vaquero C, Sanceau J, Weissenbach J, Beranger F, Falcoff R . Regulation of human gamma-interferon and beta-interferon gene expression in PHA-activated lymphocytes. J Interferon Res. 1986; 6(2):161-70. DOI: 10.1089/jir.1986.6.161. View